Reason for request
Re-assessment of the Actual Benefit and Improvement in Actual Benefit for the symptomatic treatment of idiopathic restless legs syndrome (RLS at the request of the Committee (pursuant to article R 163-21 of the French Social Security Code).
Clinical Benefit
| Moderate |
Moderate in patients with very severe idiopathic RLS. |
Clinical Added Value
| minor |
SIFROL provides a minor improvement in actual benefit (IAB IV) in the management of patients with very severe idiopathic restless legs syndrome. |
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
6UX1grVAELE3SCjh
